AngioDynamics Says Rival Must Stay In $145M Damages Row

By David Matthews · September 19, 2018, 9:51 PM EDT

Medical device maker AngioDynamics Inc. pushed back Wednesday against a competitor's attempt to toss racketeering claims, arguing in Massachusetts federal court that the competitor is culpable in Biolitec AG's alleged scheme...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

AngioDynamics, Inc. v. Wolfgang Neuberger, et al.,

Case Number

3:18-cv-30038

Court

Massachusetts

Nature of Suit

Racketeer/Corrupt Organization

Date Filed

March 15, 2018